USPTO serial 99401846
ISOCLEAR
Reviewed by CopyMark Law Group
Status 653
- Filing date
- Status date
- Registration date
- —
- Examiner
- SIME, JONATHAN PAUL
- Law office
- TMO LAW OFFICE 138
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ISOCLEAR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ben Natter
Ben Natter Haug Partners LLP745 Fifth AveNew York, NY 10151United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chromatography absorbents and adsorbents, namely resins for isoagglutinin removal and depletion; chromatography separation media for isoagglutinin removal and depletion; nanofiber filtering media for isoagglutinin removal and depletion other than for medical or veterinary purposes; particulate and nanofiber filtering media for isoagglutinin removal or depletion other than for medical or veterinary purposes; chemical and biological absorbents and adsorbents, namely resins for isoagglutinin removal and depletion other than for medical or veterinary purposes; immunoglobulin binding adsorbent, namely resins for scientific and research use; chemical and biological purifying agents, namely resins for isoagglutinin removal and depletion from chemical and biological preparations, other than for medical or veterinary purposes; chemicals and biologicals, namely resins for use in bio separation for isoagglutinin removal and depletion, other than for medical or veterinary purposes; chemicals and biologicals, namely resins for use in filtering for isoagglutinin removal and depletion, other than for medical or veterinary purposes; chemical and biological substances, namely resins for use in separation for isoagglutinin removal and depletion, other than for medical or veterinary purposes; particles or fibres of inorganic media for separation purposes for isoagglutinin removal and depletion, other than for medical or veterinary purposes; particles or fibres of polymeric media for separation purposes for isoagglutinin removal and depletion, other than for medical or veterinary purposes, namely resins; enzymes for scientific and industrial use; reagents, antibodies and intravenous gamma globulin (IVIG), namely pooled antibodies for scientific and research use other than for medical use; synthetic ligands for scientific and research use; biochemicals, namely antibodies and antibody fragments for in vitro scientific or research use. | ACTIVE | — |
| 005 | Proteins, namely antibodies and enzymes for medical diagnostic purposes; antibodies for medical use; intravenous gamma globulin (IVIG), namely, pooled antibodies for medical use; plasma and plasma products for medical use; nucleic acids for medical use; viral particles for medical use; extracellular vesicles for medical use; advanced therapeutic medicinal products for medical use, namely resins for isoagglutinin removal and depletion; enzymes for medical use; medical and clinical diagnostic reagents; insulin and insulin analogues; chromatography separation media for use with blood, plasma and plasma products for medical purposes; filtering media for isoagglutinin removal and depletion comprising of chemicals and biologicals for medical or veterinary purposes; chemical and biological absorbents and adsorbents for isoagglutinin removal and depletion for medical or veterinary purposes; immunoglobulin binding adsorbent for medical and veterinary use; chemical and biological purifying agents for isoagglutinin removal and depletion from chemical and biological preparations, for medical or veterinary purposes; chemicals and biological reagents for use in bio separation for isoagglutinin removal and depletion, for medical or veterinary purposes; chemicals and biological reagents for use in filtering for isoagglutinin removal and depletion, for medical or veterinary purposes; chemical and biological substances for use in separation for isoagglutinin removal or depletion, for medical or veterinary purposes; blood, plasma, plasma products, namely blood plasma, nucleic acids, viral vectors and extracellular vesicles for scientific and research use other than for medical use. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 10, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jul 10, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jul 10, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 19, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 15, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| May 30, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 29, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 29, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 2, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 2, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 2, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 11, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 9, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 19, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 19, 2025 | NWAP | NEW APPLICATION ENTERED | — |